India undefined Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) Q4 2024 Earnings Call Transcript Highlights: Strong Annual Performance Amid Quarterly Challenges
Despite a challenging Q4, IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) shows resilience with robust annual growth and strategic export expansion. Sep 13, 2024
GuruFocus Research Drug Manufacturers
IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) Q1 2025 Earnings Call Transcript Highlights: Mixed Performance Amid Market Challenges
Company reports a decline in total income and net profit, but maintains strong cash position and strategic focus on non-ibuprofen API expansion. Sep 13, 2024
GuruFocus Research Real Estate
Ashiana Housing Ltd (BOM:523716) Q3 2024 Earnings Call Transcript Highlights: Mixed Performance Amidst Strategic Expansion Plans
Despite a decline in booked area and revenue, Ashiana Housing Ltd (BOM:523716) shows resilience with improved profitability and ambitious future projects. Sep 13, 2024
GuruFocus Research Real Estate
Ashiana Housing Ltd (BOM:523716) Q1 2025 Earnings Call Transcript Highlights: Key Takeaways from a Challenging Quarter
Despite a drop in bookings and a negative PAT, Ashiana Housing Ltd (BOM:523716) maintains its FY25 presales guidance and plans new project launches. Sep 13, 2024